Skip to main content

Table 1 Characteristics of included studies (n = 7)

From: The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis

Study

Study area

Study design

Study period

Age (years)

Specimen

Methods employed

Participants

IPT Follow up in months

Experimental

Control

Events

Total

Events

Total

Abossie et al., 2017 [21]

Arba Minch, SNNP

RCS

Sep 2010 - Aug 2011

25–34

Sputum

Microscopy

271

6 months

12

138

37

133

Alemu et al., 2016 [25]

West Gojjam and South Gondar, Amhara

RCS

Sep 2009 -Sep 2014

1–15

Sputum

Microscopy, CXR and histopathology

645

6 months

11

119a

6

526

Nigussie et al., 2015 [22]

Addis Ababa

RCS

Aug 2014 - May2015

>  15

Sputum

Microscopy and CX

480

6 months

12

160

58

320

Edessa et al., 2014 [23]

Addis Ababa

RCS

Sep 2009 - Mar 2012

>  18

N/S

N/S

742

6 months

5

185

75

557

Yirdaw et al., 2014 [24]

Southern Ethiopia, SNNP

RCS

Sep 2007 - Aug 2010

0.16–82

Sputum

Microscopy and CXR

5407

6 months

51

2131

244

3276

Semu et al., 2017 [26]

Addis Ababa

RCS

2007 - Jan 2010

Adults

N/S

N/S

1842

12 months

4

942

71

900

Ahmed et al., 2015 [27]

North-eastern Ethiopia, Afar

RCS

July 2010 - May 2015

>  15

N/S

N/S

451

12 months

4

94

115

357

  1. Keys: CXR Chest x-ray, N/S not specified, RCS Retrospective cohort study, SNNP Southern nations nationalities and peoples of Ethiopia, aadministered IPT concomitantly with Cotrimoxazole